Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2019 June;60(3) > The Journal of Cardiovascular Surgery 2019 June;60(3):325-31

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW  RECENT ADVANCES IN THE TREATMENT OF CAROTID ARTERY DISEASE 

The Journal of Cardiovascular Surgery 2019 June;60(3):325-31

DOI: 10.23736/S0021-9509.19.10910-X

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Clinical and surrogate endpoints in future studies on outcome of carotid revascularization

Ludovica ETTORRE 1, Luca GIOVANNACCI 1, Jos C. van den BERG 2, 3

1 Service of Vascular Surgery, Centro Vascolare Ticino, Ospedale Regionale di Lugano, sede Civico, Lugano, Switzerland; 2 Service of Interventional Radiology, Centro Vascolare Ticino, Ospedale Regionale di Lugano, sede Civico, Lugano, Switzerland; 3 Inselspital, Universitätsspital Bern Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Bern, Switzerland



This paper will provide a comparison of classical endpoints like stroke and mortality versus biochemical (non-STEMI) myocardial infarction and DW-MRI new brain lesions and will discuss the importance of cranial nerve lesion in CEA. An overview of possible endpoints of future randomized clinical trials will be given.


KEY WORDS: Cerebral revascularization; Carotid endarterectomy; Carotid arteries; Stents

inizio pagina